SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NPSP NPS Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (355)10/25/2013 3:09:55 PM
From: tuck  Read Replies (1) of 363
 
BLA for Natpara submitted. Good to see, as that is in line with the latest guidance. This being an orphan drug, and unpartnered, they may choose to go it alone. This might mesh with their unpartnered drugs under development, which also address fairly small, related niches, and could be marketed by the same small sales force. Perhaps they have given guidance on this issue and I have missed it, but the recent secondary makes more sense if they expect to launch Natpara on their own.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News